Erik Deichmann Heegaard
No más puestos en curso
Fortuna: - $ al 31/03/2024
Perfil
Erik Deichmann Heegaard worked as a Medical Director in Novartis Corp.
He then worked as the Chief Medical Officer-GLP 1 Project in Novo Nordisk A from 2011 to 2014.
Currently, he is working as the Chief Medical Officer in Evaxion Biotech A from 2021 to 2023.
Dr. Deichmann Heegaard completed his undergraduate and doctorate degrees from the University of Copenhagen.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EVAXION BIOTECH A/S
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Antiguos cargos conocidos de Erik Deichmann Heegaard.
| Empresas | Cargo | Fin |
|---|---|---|
| EVAXION BIOTECH A/S | Chief Tech/Sci/R&D Officer | 01/03/2023 |
| NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formación de Erik Deichmann Heegaard.
| University of Copenhagen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| EVAXION BIOTECH A/S | Health Technology |
| Empresas privadas | 1 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Erik Deichmann Heegaard
